all report title image

BIOPHARMACEUTICAL CMO AND CRO MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Biopharmaceutical CMO and CRO Market, By Source (Mammalian and Non-mammalian), By Service (Contract Manufacturing and Contract Research), and By Product (Biologics and Biosimilars), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

  • Published In: 26 Mar, 2026
  • Code: CMI5933
  • Page number: 160
  • Formats:   Excel and PDF
  • Industry: Medical Devices
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Source
      • Market Snapshot, By Service
      • Market Snapshot, By Product
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Growing trend of outsourcing across the globe
      • Stringent regulatory framework
      • Rapid growth of the biopharmaceutical industry
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Biopharmaceutical CMO and CRO Market, By Source, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Mammalian
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Non-mammalian
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  5. Global Biopharmaceutical CMO and CRO Market, By Service, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Contract Manufacturing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Contract Research
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  6. Global Biopharmaceutical CMO and CRO Market, By Product, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Biologics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Biosimilars
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  7. Global Biopharmaceutical CMO and CRO Market, By Region, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • South Africa
        • North Africa
        • Central Africa
  8. Competitive Landscape

    • Allphase Clinical Research
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AlcheraBio
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Alcami
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Akos Urgent Care
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Agilent
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AGC Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Affinity Life Sciences, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Actimus Bio
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • ACI Clinical
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Accumedix, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Absorption Systems
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • A10 Clinical Solutions
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Albuquerque Clinical Trials (ACT)
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ajinomoto Bio-Pharma Services
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Advanced Clinical Services LLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • ACM Global Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Accelerated Enrollment Solutions
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Contract Manufacturing
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Advanced BioScience Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Advanced Clinical Research Institute
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Alliance for Clinical Trials in Oncology
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Analyst Views
  9. Section

    • Research Methodology
    • About us
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.